Literature DB >> 19412621

Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients.

Tsuguhiko Seo1, Atsushi Tatsuguchi, Seiichi Shinji, Masaoki Yonezawa, Keigo Mitsui, Shu Tanaka, Shunji Fujimori, Katya Gudis, Yuh Fukuda, Choitsu Sakamoto.   

Abstract

The aim of this study is to investigate the expression of three prostaglandin E synthase (PGES) isomers in colorectal cancer (CRC) tissue and to evaluate their relationship to clinicopathological factors and patient prognosis. Microsomal PGES (mPGES)-1, mPGES-2, cytosolic PGES (cPGES) and cyclooxygenase (COX)-2 protein expression were analyzed by real-time polymerase chain reaction and Western blot. The localization of each PGES and COX-2 protein was examined by immunohistochemistry in 155 surgical resections and correlated to clinicopathological factors and patient prognosis. mPGES-1 mRNA and protein levels were significantly higher in CRC than in paired normal tissues. mPGES-1 immunoreactivity localized in cancer cells in 43% of cases. mPGES-2 immunoreactivity was significantly more pronounced in cancer cells than in adjacent normal epithelium in 36% of cases. cPGES immunoreactivity was homogeneous in cancer cells and thus determined constitutive. mPGES-1 and mPGES-2 correlated with significantly worse prognosis in stage I-III patients. These results indicate that mPGES-1 and mPGES-2 may each play a role in CRC progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412621     DOI: 10.1007/s00428-009-0777-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

Review 1.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 3.  Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.

Authors:  Frank A Sinicrope
Journal:  Mol Carcinog       Date:  2006-06       Impact factor: 4.784

4.  Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression.

Authors:  Rui Han; Shanli Tsui; Terry J Smith
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

5.  Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.

Authors:  S Tanaka; A Tatsuguchi; S Futagami; K Gudis; K Wada; T Seo; K Mitsui; M Yonezawa; K Nagata; S Fujimori; T Tsukui; T Kishida; C Sakamoto
Journal:  Gut       Date:  2005-08-05       Impact factor: 23.059

6.  Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells.

Authors:  D O Stichtenoth; S Thorén; H Bian; M Peters-Golden; P J Jakobsson; L J Crofford
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

Review 7.  Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis.

Authors:  Ichiro Kudo; Makoto Murakami
Journal:  J Biochem Mol Biol       Date:  2005-11-30

8.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

Authors:  T Kawamori; C V Rao; K Seibert; B S Reddy
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

9.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase.

Authors:  Naomi Tanikawa; Yoshihiro Ohmiya; Hiroaki Ohkubo; Katsuyuki Hashimoto; Kenji Kangawa; Masami Kojima; Seiji Ito; Kikuko Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

10.  Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

Authors:  Makoto Murakami; Karin Nakashima; Daisuke Kamei; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Yoshihiro Ohmiya; Kikuko Watanabe; Ichiro Kudo
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

View more
  15 in total

1.  Expression profile of polyunsaturated fatty acids in colorectal cancer.

Authors:  Kai Yang; Hong Li; Jin Dong; Yan Dong; Chang-Zheng Wang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

2.  Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.

Authors:  Ian W Saunders; Jason Ross; Finlay Macrae; Graeme P Young; Ignacio Blanco; Jesper Brohede; Glenn Brown; Diana Brookes; Trevor Lockett; Peter L Molloy; Victor Moreno; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

3.  Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue.

Authors:  F Jahns; A Wilhelm; N Jablonowski; H Mothes; Mariya Radeva; A Wölfert; K O Greulich; M Glei
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

Review 4.  mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".

Authors:  Masako Nakanishi; Vijay Gokhale; Emmanuelle J Meuillet; Daniel W Rosenberg
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

5.  FosB transcription factor regulates COX-2 expression in colorectal cancer cells without affecting PGE2 expression.

Authors:  Diana Lizeth Cervantes-Madrid; Sabah Nagi; Annika Asting Gustafsson
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

6.  Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro.

Authors:  Fusao Takusagawa
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

7.  Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.

Authors:  James J Lee; Mitsuteru Natsuizaka; Shinya Ohashi; Gabrielle S Wong; Munenori Takaoka; Carmen Z Michaylira; Daniela Budo; John W Tobias; Michiyuki Kanai; Yasuhiro Shirakawa; Yoshio Naomoto; Andres J P Klein-Szanto; Volker H Haase; Hiroshi Nakagawa
Journal:  Carcinogenesis       Date:  2009-12-30       Impact factor: 4.944

Review 8.  Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy.

Authors:  Lisa Y Pang; Emma A Hurst; David J Argyle
Journal:  Stem Cells Int       Date:  2016-11-01       Impact factor: 5.443

9.  Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue.

Authors:  ElKhansa Sidahmed; Ananda Sen; Jianwei Ren; Arsh Patel; D Kim Turgeon; Mack T Ruffin; Dean E Brenner; Zora Djuric
Journal:  Nutr Cancer       Date:  2016-08-22       Impact factor: 2.900

10.  Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression.

Authors:  Konstantinos Stamatakis; Marta Jimenez-Martinez; Alba Jimenez-Segovia; Isabel Chico-Calero; Elisa Conde; Javier Galán-Martínez; Julia Ruiz; Alejandro Pascual; Beatriz Barrocal; Ricardo López-Pérez; María Laura García-Bermejo; Manuel Fresno
Journal:  Oncotarget       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.